ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABHD1 | Abhydrolase domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ABHD12 | Abhydrolase domain containing 12 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ABHD13 | Abhydrolase domain containing 13 | Predicted membrane proteins
| | | | | Expressed in all |
ABHD14A | Abhydrolase domain containing 14A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD15 | Abhydrolase domain containing 15 | Predicted secreted proteins
| | | | | Mixed |
ABHD16A | Abhydrolase domain containing 16A | Predicted membrane proteins
| | | | | Expressed in all |
ABHD16B | Abhydrolase domain containing 16B | Plasma proteins
| | | | | Mixed |
ABHD2 | Abhydrolase domain containing 2 | Predicted membrane proteins
| | | | | Expressed in all |
ABHD3 | Abhydrolase domain containing 3 | Predicted membrane proteins
| | | | | Expressed in all |
ABHD4 | Abhydrolase domain containing 4 | Enzymes
| | | | | Expressed in all |
ABHD5 | Abhydrolase domain containing 5 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ABHD6 | Abhydrolase domain containing 6 | Enzymes Predicted membrane proteins
| | | | | Mixed |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| | | | | Expressed in all |
ABTB2 | Ankyrin repeat and BTB (POZ) domain containing 2 | | | | | | Mixed |
AC002398.9 | Uncharacterized protein | Predicted membrane proteins
| | | | | Mixed |
AC006538.4 | Uncharacterized protein | Predicted membrane proteins
| | | | | Mixed |
AC011484.1 | Uncharacterized protein; cDNA FLJ42076 fis, clone SYNOV2018921 | | | | | | Not detected |
AC011755.1 | HCG2006742; Protein LOC100996685 | Predicted membrane proteins
| | | | | Not detected |
AC015987.2 | | Predicted membrane proteins
| | | | | Expressed in all |
AC016251.1 | | | | | | | Not detected |
AC026703.1 | | Predicted membrane proteins
| | | | | Tissue enhanced |
AC040160.1 | Uncharacterized protein; cDNA FLJ57407, weakly similar to Mus musculus leucine rich repeat containing 29 (Lrrc29), mRNA | | | | | | Not detected |
AC114783.1 | Protein LOC339760 | Predicted secreted proteins
| | | | | Tissue enriched |
AC132216.1 | HCG1785179; PRO1787; Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enriched |
AC145205.1 | | | | | | | Not detected |
ACAA1 | Acetyl-CoA acyltransferase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
ACAA2 | Acetyl-CoA acyltransferase 2 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ACACA | Acetyl-CoA carboxylase alpha | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACAD11 | Acyl-CoA dehydrogenase family, member 11 | | | | | | Expressed in all |
ACAD8 | Acyl-CoA dehydrogenase family, member 8 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ACAD9 | Acyl-CoA dehydrogenase family, member 9 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ACADL | Acyl-CoA dehydrogenase, long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Mixed |
ACADM | Acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACADS | Acyl-CoA dehydrogenase, C-2 to C-3 short chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACADSB | Acyl-CoA dehydrogenase, short/branched chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACADVL | Acyl-CoA dehydrogenase, very long chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACAT1 | Acetyl-CoA acetyltransferase 1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACAT2 | Acetyl-CoA acetyltransferase 2 | Enzymes Plasma proteins
| | | | | Expressed in all |
ACBD4 | Acyl-CoA binding domain containing 4 | Predicted membrane proteins
| | | | | Expressed in all |
ACBD5 | Acyl-CoA binding domain containing 5 | Predicted membrane proteins
| | | | | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACER1 | Alkaline ceramidase 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
ACER2 | Alkaline ceramidase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACKR3 | Atypical chemokine receptor 3 | Cancer-related genes G-protein coupled receptors Predicted membrane proteins
| | | | | Expressed in all |
ACO1 | Aconitase 1, soluble | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |